KalVista Pharmaceuticals (KALV) Enterprise Value (QoQ) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 13.21% |
| Oct 31, 2024 | 22.09% |
| Jul 31, 2024 | 17.17% |
| Apr 30, 2024 | -178.36% |
| Jan 31, 2024 | 26.74% |
| Oct 31, 2023 | 16.30% |
| Jul 31, 2023 | 17.48% |
| Apr 30, 2023 | 12.99% |
| Jan 31, 2023 | -40.41% |
| Oct 31, 2022 | 13.94% |
| Jul 31, 2022 | 14.52% |
| Apr 30, 2022 | 14.68% |
| Jan 31, 2022 | 7.16% |
| Oct 31, 2021 | 9.03% |
| Jul 31, 2021 | 7.35% |
| Apr 30, 2021 | -394.78% |
| Jan 31, 2021 | 9.96% |
| Oct 31, 2020 | 13.15% |
| Jul 31, 2020 | 5.00% |
| Apr 30, 2020 | 15.96% |
| Jan 31, 2020 | 13.79% |
| Oct 31, 2019 | 6.88% |
| Jul 31, 2019 | 0.44% |
| Apr 30, 2019 | 9.30% |
| Jan 31, 2019 | 8.23% |
| Oct 31, 2018 | -151.96% |
| Jul 31, 2018 | 5.85% |
| Apr 30, 2018 | 12.99% |
| Jan 31, 2018 | -108.61% |
| Oct 31, 2017 | -6.32% |
| Jul 31, 2017 | 14.52% |
| Apr 30, 2017 | 7.61% |
| Jan 31, 2017 | -213.48% |
| Oct 31, 2016 | 31.62% |
| Mar 31, 2016 | 9.55% |
| Dec 31, 2015 | 10.28% |
| Sep 30, 2015 | 8.42% |
| Jun 30, 2015 | -1,955.36% |
| Mar 31, 2015 | 18.37% |
| Dec 31, 2014 | 58.21% |
| Sep 30, 2014 | -29.95% |
| Jun 30, 2014 | 22.64% |